Last reviewed · How we verify

NCT03563625

Local Wound Infiltration Versus Caudal Block on Wound Infection and Healing in Paediatrics Inguinal Herniotomy

Completed NA Last updated 11 December 2018
What this trial tests

NA trial testing Caudal block in Healing Surgical Wounds in 50 participants. Completed in 6 November 2018.

Timeline
4 November 2017
Primary endpoint
30 October 2018
6 November 2018

Quick facts

Lead sponsorUniversity of Alexandria
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment50
Start date4 November 2017
Primary completion30 October 2018
Estimated completion6 November 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

University of Alexandria

Who can join

Adults 2 Months to 12 Months, any sex, with Healing Surgical Wounds. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present study is to assess effect of local wound infiltration in comparison with caudal block by bupivacaine 0.25% after inguinal herniotomy in pediatrics on: Wound infection and healing (primary outcome) and postoperative analgesia (secondary outcome).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Caudal block

Trials testing the same drug.

Other recruiting trials for Healing Surgical Wounds

Currently open trials in the same condition.

Other University of Alexandria trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03563625.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing